RT @ASBMR: The objective of a new #JBMR clinical trial was to evaluate the potential therapeutic advantage of Ca-Cit in comparison with calcium carbonate in HypoPT, on nephrolithiasis risk factors #ASBMR #openaccess #freetoread @WileyBiomedical https://t.co/zvEGs8Mggn https://t.co/tmSpGHaIvT


from Twitter https://twitter.com/GastonR48222321

June 30, 2022 at 08:15AM

Comentarios

Entradas más populares de este blog

RT @ECTS_soc: Today is #PagetsAwarenessDay2022. The Paget’s Association has released a video series with a global perspective on Paget’s disease, presented by Dr Tori Herridge, an evolutionary biologist and presenter on Ch4’s Bone Detectives series. Watch now -https://t.co/m1A9MhbOnF https://t.co/zEQzdo4FWH

RT @GEHealthCare: It's often said that there is no greater gift than making someone smile. That's exactly the gift our team in Australia and New Zealand gave when they put together "Sparkle packs" full of toys for local sick children. Thank you for making their days! 💜 https://t.co/E1FLt2EuO7